ReShape Lifesciences, Inc.

Q2 2024 13F Holders

Symbol
RSLS
CUSIP
76090R200
Type
Equity
Class
COM
Num filings
19
Total reported value, excl. options
$73.3 k
Manager Report Date Value ($000) Shares Option Type